Virtual Reality During Intrathecal Pump Refills in Children

Cerebral Palsy Clinical Trial

— VAMPIRE  

Official title:

Virtual Reality During Intrathecal Pump Refills in Children: a Randomised Controlled Trial With Crossover Design

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04737668
• Other study ID #: VAMPIRE
• Status: Completed
• Phase: N/A
• Start date: February 10, 2021
• Est. completion date: January 26, 2022

Study information

• Verified date: March 2022
• Source: Universitair Ziekenhuis Brussel
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of the current study is to explore the effect of virtual reality on pain in children who undergo an intrathecal pump refill compared to usual care and distraction.

Description:

Virtual reality (VR) is a technological rehabilitation tool that allows the user to experience the interaction with a computer-generated environment. It may provide some advantages over conventional care: it allows the simulation of realistic environments and patients feel more motivated by this kind of virtual environment. VR constitutes an enriched environment with augmented multiple sensory feedbacks (auditory, visual, tactile VR enriched environment) that has already shown some efficiency in reducing chronic pain. There is mounting evidence from acute pain conditions, such as wound care, that VR could play a role as an additional treatment method to relieve pain A possible explanation for its mechanism of action is provided by "the gate-theory of attention". VR reduces the perception of pain by diverting attention away from the pain. Most children experience pain and fear when receiving a medical treatment; two feelings which are closely related and affecting one another. Moreover, children often describe procedures involving needles as the most stressful portion of the hospital experience. Children who have been implanted with an intrathecal baclofen (ITB) pump, need to come to the hospital for a refill approximately every 3 months, depending on the exact dose. During the refill, the physician places a needle directly into the reservoir to refill the pump. To alleviate the pain and fear with these refill procedures, it is hypothesized that VR could alleviate pain and make these refills more feasible. Therefore, the aim of this study is to evaluate whether VR is reducing pain during a refill procedure, in children receiving intrathecal drug delivery compared to usual care.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 6
• Est. completion date: January 26, 2022
• Est. primary completion date: January 26, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 8 Years to 16 Years

Eligibility

Inclusion Criteria:

• Children with cerebral palsy between 8 and 16 years who have an implanted pump for intrathecal drug delivery
• Child and parents have been informed of the study procedures and have given written informed consent
• Child and parents willing to comply with study protocol
• Child and parents are able to speak Dutch/French (questionnaires)
• Cognitive and language functioning enabling communication between the physician/researcher and the child

Exclusion Criteria:

• Children with susceptibility to motion sickness or cyber-sickness
• Children with susceptibility to claustrophobia
• History of seizures/epilepsia

Related Conditions & MeSH terms

• Cerebral Palsy

Intervention

Other:
• Intrathecal pump refill with Virtual Reality
VR game
• Intrathecal pump refill with distraction
Video
• Intrathecal pump refill
daily routine care for pump refill

Locations

Country	Name	City	State
Belgium	Universitair Ziekenhuis Brussel	Jette

Sponsors (1)

Lead Sponsor	Collaborator
Moens Maarten

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Pain intensity	Pain intensity will be assessed with the Wong-Baker FACES scale in children, parents, physician and researcher, to evaluate differences in the 3 conditions (usual refill, refill with VR and refill with distraction).	Through study completion, an average of 6 months.
Secondary	Procedural pain	Procedural pain during refill is assessed with the Face, Legs, Activity, Cry, Consolability scale.	Through study completion, an average of 6 months.
Secondary	Fear	The degree of fear will be measured using the Child Fear Scale, based on reporting from the child and parent.	Through study completion, an average of 6 months.
Secondary	Anxiety	The Children's Anxiety Meter (CAM) will be used to measure anxiety. This scale will be filled in by children and parents.	Through study completion, an average of 6 months.
Secondary	Statisfaction	The statisfaction will be evaluated by two questions, scoring on a 5-point Likert agreement scale, by the children, parents and physician after the refill with VR and after the refill with distraction.	Through study completion, an average of 6 months.
Secondary	Adverse events	The incidence of adverse events (nausea, vomiting, motion sickness, dizziness, seizure) will be evaluated after the refill with VR.	Through study completion, an average of 6 months.